XOMA Royalty Completes Tender Offer for HilleVax, Inc.
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 17 2025
0mins
Source: Globenewswire
Tender Offer Completion: XOMA Royalty Corporation successfully completed its tender offer to acquire all outstanding shares of HilleVax, Inc. for $1.95 per share in cash, along with a non-tradeable contingent value right, with approximately 77.48% of HilleVax shares validly tendered.
Merger and Delisting: Following the tender offer, HilleVax merged with a subsidiary of XOMA Royalty, becoming a wholly owned subsidiary, and its shares will cease trading on Nasdaq and be delisted.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
